Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06484946 · ClinicalTrials.gov registry record · NA
Pediatric Aquatic Occupational Therapy for Children With Sensory Processing Challenges
A NA study of Autism Spectrum Disorder and ADHD, sponsored by Kristen Pataki.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06484946: Completed NA study of Autism Spectrum Disorder and ADHD, sponsored by Kristen Pataki.
NCT06484946 is a NA study of Autism Spectrum Disorder and ADHD that has completed, run by Kristen Pataki. The registered enrollment target is 35 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06484946, a NA study of Autism Spectrum Disorder and ADHD, has completed, sponsored by Kristen Pataki.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
Children with sensory processing challenges participated in an 8-week play-based aquatic program addressing goals on behavior, sensory, and participation. It is expected that after the 8-week group, the child's goals will improve demonstrating an effective intervention to address sensory difficulties.
Primary Outcome
Goals were written on behavior, engagement/participation, and sensory on a scale from -2 (worse outcome) to +2 (better outcome). Each week scores on each goal were documented.
Conditions Studied
Interventions
- OTHER aquatic occupational therapy
Study Locations (1)
Ohio
- Seven Hills Recreation Center - Seven Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2024-04-09 |
| Phase | NA |
What the finished NCT06484946 record still lists
NCT06484946 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which aquatic occupational therapy is the first listed.
NCT06484946 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06484946 about?
NCT06484946 is a clinical study titled "Pediatric Aquatic Occupational Therapy for Children With Sensory Processing Challenges". Children with sensory processing challenges participated in an 8-week play-based aquatic program addressing goals on behavior, sensory, and participation. It is expected that after the 8-week group, the child's goals will improve demonstrating an effective intervention to address sensory difficultie...
What is the current status of trial NCT06484946?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-02-19. Estimated completion is 2024-04-09.
What conditions does trial NCT06484946 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, ADHD, Sensory Processing Disorder.
What interventions are being tested in trial NCT06484946?
The interventions under investigation include: aquatic occupational therapy (OTHER).
Who is sponsoring clinical trial NCT06484946?
This trial is sponsored by Kristen Pataki, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06484946 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06484946's enrollment target sits among peer trials
35 167th of 224 higher than 58 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI